Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 2
2008 5
2009 7
2010 7
2011 2
2012 9
2013 7
2014 5
2015 5
2016 1
2017 2
2019 8
2020 3
2021 9
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean zhang zhen lin (124 results)?
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Kim RD, Sarker D, Meyer T, Yau T, Macarulla T, Park JW, Choo SP, Hollebecque A, Sung MW, Lim HY, Mazzaferro V, Trojan J, Zhu AX, Yoon JH, Sharma S, Lin ZZ, Chan SL, Faivre S, Feun LG, Yen CJ, Dufour JF, Palmer DH, Llovet JM, Manoogian M, Tugnait M, Stransky N, Hagel M, Kohl NE, Lengauer C, Sherwin CA, Schmidt-Kittler O, Hoeflich KP, Shi H, Wolf BB, Kang YK. Kim RD, et al. Among authors: lin zz. Cancer Discov. 2019 Dec;9(12):1696-1707. doi: 10.1158/2159-8290.CD-19-0555. Epub 2019 Oct 1. Cancer Discov. 2019. PMID: 31575541 Free article. Clinical Trial.
Sunitinib-induced myxedema coma.
Chen SY, Kao PC, Lin ZZ, Chiang WC, Fang CC. Chen SY, et al. Among authors: lin zz. Am J Emerg Med. 2009 Mar;27(3):370.e1-370.e3. doi: 10.1016/j.ajem.2008.07.012. Am J Emerg Med. 2009. PMID: 19328392 No abstract available.
Clinical trials in hepatocellular carcinoma: an update.
Shen YC, Lin ZZ, Hsu CH, Hsu C, Shao YY, Cheng AL. Shen YC, et al. Among authors: lin zz. Liver Cancer. 2013 Aug;2(3-4):345-64. doi: 10.1159/000343850. Liver Cancer. 2013. PMID: 24400222 Free PMC article. Review.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Kelley RK, Miksad R, Cicin I, Chen Y, Klümpen HJ, Kim S, Lin ZZ, Youkstetter J, Hazra S, Sen S, Cheng AL, El-Khoueiry AB, Meyer T, Abou-Alfa GK. Kelley RK, et al. Among authors: lin zz. Br J Cancer. 2022 Mar;126(4):569-575. doi: 10.1038/s41416-021-01532-5. Epub 2021 Oct 7. Br J Cancer. 2022. PMID: 34621044 Free PMC article. Clinical Trial.
68 results